Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Exploring Foreign Epitopes Recogniton in Personalized Medicines with Vibha Jawa

May 04, 2023

Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.

Ramping Up Nucleic Acid Therapy Development

May 03, 2023

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

Using Smart Tools for Smart Development

May 03, 2023

The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

May 03, 2023

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.

Frontrunner in Organ-on-a-Chip

May 03, 2023

Competition in the organ-on-a-chip market increases as NETRI enters the arena.

Continuous Hot-Melt Extrusion for Poorly Soluble APIs

May 02, 2023

Process control is essential for using continuous hot-melt extrusion to enhance solubility.

Envisioning Digital Pharma Manufacturing

May 02, 2023

Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

May 02, 2023

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Exploring Bile Acid Therapeutics with Roger Viney (DCAT Week)

May 01, 2023

Roger Viney, chief commercial officer at ICE Pharma, discusses the history and current use of bile acid therapeutics.

Webcasts

Early Phase Development and CDMOs in the Outsourcing Landscape

April 27, 2023

Webinar Date/Time: Friday, May 19, 2023 at 11am EDT| 10am CDT | 8am PDT